Yahoo Italia Ricerca nel Web

Entra

Risultati di ricerca

  1. www.qlibri.it › narrativa-straniera › romanziGilead - Marilynne Robinson - Recensioni di QLibri

    4 giorni fa · Solo dopo diversi incontri e una confessione da parte del giovane Boughton, Ames capirà che anche Jack è un'anima tormentata alla ricerca di un'oasi di salvezza, un figliol prodigo caduto in disgrazia a causa delle sue debolezze, ma anche una vittima di assurdi pregiudizi religiosi e razziali.

  2. www.gilead.com › news-and-press › press-roomGilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen...

    5 giorni fa · ARC-9 (NCT04660812) is a Phase 1b/2 trial evaluating the safety and efficacy of etrumadenant (E), a dual A2a/A2b adenosine receptor antagonist, plus anti-PD-1 antibody zimberelimab (Z), FOLFOX and bevacizumab (if not contraindicated) in three cohorts of patients with mCRC.

  3. acquirersmultiple.com › 2024 › 06This Acquirers Multiple Stock Is Undervalued, According to Dalio...

    1 giorno fa · Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer.

  4. www.borsaitaliana.it › borsa › azioniAzioni Gilead Sciences: quotazioni in tempo reale - Borsa...

    4 giorni fa · Azioni Gilead Sciences in tempo reale (US3755581036). Scopri quotazioni, analisi tecnica, grafici interattivi e ultime notizie del titolo.

  5. www.marketscreener.com › quote › stockGilead Sciences, Inc. Stock - MarketScreener.com

    1 giorno fa · Gilead Sciences, Inc. and Arcus Biosciences, Inc. Announce Anti-TIGIT Domvanalimab Plus Zimberelimab and Chemotherapy Exceeded One Year of Median Progression-Free Survival as A First-Line Treatment for Upper GI Cancers. Jun. 01.

    • (26)
    • GILEAD SCIENCES, INC.

  6. www.dallascollege.edu › news › pagesDallas College News Update – News – Dallas College

    2 giorni fa · Dallas College Announces Board Updates Following 2024 Elections. Dr. Catalina Garcia was reelected trustee of District 1. Media Contact: Cherie Yurco; CMYurco@DallasCollege.edu. For immediate release — June 5, 2024. (DALLAS) — Just prior to the Dallas College Board of Trustees meeting on Tuesday, June 4, the reelected Dr. Catalina Garcia ...

  7. deal.town › gilead-sciences › gilead---gilead-and-arcusGilead - Gilead and Arcus Announce Anti-TIGIT Domvanalimab Plus...

    6 giorni fa · Gilead - Gilead and Arcus Announce Anti-TIGIT Domvanalimab Plus Zimberelimab and Chemotherapy Exceeded One Year of Median Progression-Free Survival as a First-Line Treatment for Upper GI Cancers. Gilead Sciences sent this email to their subscribers on June 1, 2024.